Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis

Clinical Biochemistry

Volumn 43, Issue 1-2, 2010, Pages 150-158

  Chow, Tsz fung F ^a   Youssef, Youssef M ^a   Lianidou, Evi ^b   Romaschin, Alexander D ^a,c   Honey, R John ^d   Stewart, Robert ^d   Pace, Kenneth T ^d   Yousef, George M ^a,c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Bioinformatics; Kidney cancer; Microarray; microRNA; miRNA; Renal cell carcinoma; RT PCR; Tumor markers

Indexed keywords

MICRORNA;

ARTICLE; BIOINFORMATICS; CANCER TISSUE; CARCINOGENESIS; CHROMOSOME ABERRATION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE TARGETING; GENETIC ALGORITHM; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MICROARRAY ANALYSIS; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION;

CARCINOMA, RENAL CELL; CHROMOSOME MAPPING; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MICROARRAY ANALYSIS; MICRORNAS; TUMOR MARKERS, BIOLOGICAL;

EID: 72649084669     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.07.020     Document Type: Article

References (53)

1. Gottardo F., Liu C.G., Ferracin M., Calin G.A., Fassan M., Bassi P., et al. Micro-RNA profiling in kidney and bladder cancers. Urol. Oncol. 25 5 (2007 September) 387-392
2. Garzon R., Pichiorri F., Palumbo T., Visentini M., Aqeilan R., Cimmino A., et al. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 26 28 (2007 June 14) 4148-4157
3. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6 11 (2006 November) 857-866
4. Cullen B.R. Transcription and processing of human microRNA precursors. Mol Cell 16 6 (2004 December 22) 861-865
5. Esquela-Kerscher A., and Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 6 4 (2006 April) 259-269
6. Fulci V., Chiaretti S., Goldoni M., Azzalin G., Carucci N., Tavolaro S., et al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109 11 (2007 June 1) 4944-4951
7. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103 7 (2006 February 14) 2257-2261
8. Lu J., Getz G., Miska E.A., varez-Saavedra E., Lamb J., Peck D., et al. MicroRNA expression profiles classify human cancers. Nature 435 7043 (2005 June 9) 834-838
9. Nikiforova M.N., Tseng G.C., Steward D., Diorio D., and Nikiforov Y.E. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J. Clin. Endocrinol. Metab. 93 5 (2008 (May) 1600-1608
10. Bandres E., Cubedo E., Agirre X., Malumbres R., Zarate R., Ramirez N., et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer 5 (2006) 29
11. Bottoni A., Zatelli M.C., Ferracin M., Tagliati F., Piccin D., Vignali C., et al. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J. Cell Physiol. 210 2 (2007 February) 370-377
12. Calin G.A., Liu C.G., Sevignani C., Ferracin M., Felli N., Dumitru C.D., et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. U. S. A. 101 32 (2004 August 10) 11755-11760
13. Ciafre S.A., Galardi S., Mangiola A., Ferracin M., Liu C.G., Sabatino G., et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun. 334 4 (2005 September 9) 1351-1358
14. Gramantieri L., Ferracin M., Fornari F., Veronese A., Sabbioni S., Liu C.G., et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 67 13 (2007 July 1) 6092-6099
15. Hayashita Y., Osada H., Tatematsu Y., Yamada H., Yanagisawa K., Tomida S., et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 65 21 (2005 November 1) 9628-9632
16. He H., Jazdzewski K., Li W., Liyanarachchi S., Nagy R., Volinia S., et al. The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. U. S. A. 102 52 (2005 December 27) 19075-19080
17. He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S., et al. A microRNA polycistron as a potential human oncogene. Nature 435 7043 (2005 June 9) 828-833
18. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65 16 (2005 August 15) 7065-7070
19. Lee E.J., Gusev Y., Jiang J., Nuovo G.J., Lerner M.R., Frankel W.L., et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer 120 5 (2007 March 1) 1046-1054
20. Lui W.O., Pourmand N., Patterson B.K., and Fire A. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res. 67 13 (2007 July 1) 6031-6043
21. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., and Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133 2 (2007 August) 647-658
22. Murakami Y., Yasuda T., Saigo K., Urashima T., Toyoda H., Okanoue T., et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25 17 (2006 April 20) 2537-2545
23. Pallante P., Visone R., Ferracin M., Ferraro A., Berlingieri M.T., Troncone G., et al. MicroRNA deregulation in human thyroid papillary carcinomas. Endocr. Relat. Cancer 13 2 (2006 June) 497-508
24. Porkka K.P., Pfeiffer M.J., Waltering K.K., Vessella R.L., Tammela T.L., and Visakorpi T. MicroRNA expression profiling in prostate cancer. Cancer Res. 67 13 (2007 (July 1) 6130-6135
25. Szafranska A.E., Davison T.S., John J., Cannon T., Sipos B., Maghnouj A., et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26 30 (2007 June 28) 4442-4452
26. Tran N., McLean T., Zhang X., Zhao C.J., Thomson J.M., O' Brien C., et al. MicroRNA expression profiles in head and neck cancer cell lines. Biochem. Biophys. Res. Commun. 358 1 (2007 June 22) 12-17
27. Visone R., Pallante P., Vecchione A., Cirombella R., Ferracin M., Ferraro A., et al. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26 54 (2007 November 29) 7590-7595
28. Wang T., Zhang X., Obijuru L., Laser J., Aris V., Lee P., et al. A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer 46 4 (2007 April) 336-347
29. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 3 (2006 March) 189-198
30. Griffiths-Jones S., Saini H.K., van D.S., and Enright A.J. miRBase: tools for microRNA genomics. Nucleic Acids Res. 36 Database issue (2008 (January)) D154-D158
31. Mitelman F JBaMF. Mitelman Database of Chromosome Aberrations in Cancer (2008). Mitelman F, Johansson B and Mertens F (Eds.). Literature 8 A.D. May 23;Available from: URL: http://cgap.nci.nih.gov/Chromosomes/Mitelman.
32. Baudis M., and Cleary M.L. Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics 12 17 (2001) 1228-1229
33. Blenkiron C., and Miska E.A. miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum. Mol. Genet. 16 Spec No 1 (2007 (April 15) R106-R113
34. Rathmell W.K., and Godley P.A. Renal cell carcinoma. Curr. Opin. Oncol. 16 3 (2004 May) 247-252
35. Kulshreshtha R., Ferracin M., Wojcik S.E., Garzon R., Alder H., gosto-Perez F.J., et al. A microRNA signature of hypoxia. Mol. Cell. Biol. 27 5 (2007 (March) 1859-1867
36. Camps C., Buffa F.M., Colella S., Moore J., Sotiriou C., Sheldon H., et al. hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin. Cancer Res. 14 5 (2008 March 1) 1340-1348
37. Fasanaro P., D' Alessandra Y., Di V S., Melchionna R., Romani S., Pompilio G., et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-A3. J. Biol. Chem. 283 23 (2008 June 6) 15878-15883
38. Pulkkinen K., Malm T., Turunen M., Koistinaho J., and Yla-Herttuala S. Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS Lett. 582 (2008) 2397-2401
39. Li L., Zhang L., Zhang X., Yan Q., Minamishima Y.A., Olumi A.F., et al. Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations. Mol. Cell. Biol. 27 15 (2007 August) 5381-5392
40. Giannakakis A., Sandaltzopoulos R., Greshock J., Liang S., Huang J., Hasegawa K., et al. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol. Ther. 7 2 (2007 November) 14
41. Cho W.C. OncomiRs: the discovery and progress of microRNAs in cancers. Mol. Cancer 6 (2007) 60
42. Wong C.F., and Tellam R.L. MicroRNA-26a targets the histone methyltransferase enhancer of zeste homolog 2 during myogenesis. J. Biol. Chem. 283 15 (2008 April 11) 9836-9843
43. Verghese E., Hanby A., Speirs V., and Hughes T. Small is beautiful: microRNAs and breast cancer-where are we now?. J. Pathol. 215 3 (2008 July) 214-221
44. Lu Z., Liu M., Stribinskis V., Klinge C.M., Ramos K.S., Colburn N.H., et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27 31 (2008) 4373-4379
45. Zhu S., Si M.L., Wu H., and Mo Y.Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem. 282 19 (2007 May 11) 14328-14336
46. Zhu S., Wu H., Wu F., Nie D., Sheng S., and Mo Y.Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 18 3 (2008 March) 350-359
47. Yang H., Kong W., He L., Zhao J.J., O Donnell J.D., Wang J., et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 68 2 (2008 January 15) 425-433
48. Sylvestre Y., De V G., Querido E., Mukhopadhyay U.K., Bourdeau V., Major F., et al. An E2F/miR-20a autoregulatory feedback loop. J. Biol. Chem. 282 4 (2007 (January 26) 2135-2143
49. Sengupta S., den Boon J.A., Chen I.H., Newton M.A., Stanhope S.A., Cheng Y.J., et al. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc. Natl. Acad. Sci. U. S. A. 105 15 (2008 April 15) 5874-5878
50. Rosa A., Ballarino M., Sorrentino A., Sthandier O., De Angelis F.G., Marchioni M., et al. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc. Natl. Acad. Sci. U. S. A. 104 50 (2007 December 11) 19849-19854
51. Wenguang Z., Jianghong W., Jinquan L., and Yashizawa M. A subset of skin-expressed microRNAs with possible roles in goat and sheep hair growth based on expression profiling of mammalian microRNAs. OMICS 11 4 (2007) 385-396
52. Sun Y., Koo S., White N., Peralta E., Esau C., Dean N.M., et al. Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res. 32 22 (2004) e188
53. Razzaque M.S., Naito T., and Taguchi T. Proto-oncogene Ets-1 and the kidney. Nephron 89 1 (2001 September) 1-4